Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details)

v3.23.2
ACQUISITIONS (Details) - USD ($)
$ in Thousands
 1 Months Ended
Sep. 30, 2021
Jun. 30, 2023
Dec. 31, 2022
Sep. 10, 2021
Business Acquisition [Line Items]        
Contingent consideration liabilities - current portion   $ 2,394 $ 3,398  
Nature's Remedy        
Business Acquisition [Line Items]        
Contingent consideration, equity interest issued and issuable       $ 5,000
Contingent consideration, liability, monthly earnout $ 278      
Contingent consideration, liability, earnout calculation, ratio to share price $ 1,667      
Contingent liability   2,394 4,793  
Contingent consideration liabilities - current portion   $ 2,500 3,398  
Other liabilities - non-current     $ 1,395  
Nature's Remedy | Milestone Period One        
Business Acquisition [Line Items]        
Contingent consideration period 12 months      
Nature's Remedy | Milestone Period Two        
Business Acquisition [Line Items]        
Contingent consideration period 30 months      
Nature's Remedy | Monthly Milestone Period One        
Business Acquisition [Line Items]        
Contingent consideration period 18 months      
Nature's Remedy | Monthly Milestone Period Two        
Business Acquisition [Line Items]        
Contingent consideration period 24 months      
Nature's Remedy | Monthly Milestone Period Three        
Business Acquisition [Line Items]        
Contingent consideration period 30 months